IL-9, one of the most recent entries in the list of cytokines with effects on CLL, is secreted by several immune cells in many disease contexts where it shows both anti-tumoral [22] and pro-tumoral effects [23] that depend on the specific tumor subtype. The gene discussed is IL9; the disease is B-cell chronic lymphocytic leukemia.